MTOR and metabolic dysfunction-associated steatotic liver disease: The results of Western blot analysis showed that there was no significant difference in PI3K, Akt, and mTOR expression in the hypothalamus among control, NAFLD, and [D-Lys-3]-GHRP-6 group (n=10, P>0.05, Figure 6).